Trial
NCT05555615
Extension Study of Pimavanserin in Irritability Associated With Autism Spectrum Disorder
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
ACADIA Pharmaceuticals Inc.
Collaborators
—
Condition
Irritability Associated With Autism Spectrum Disorder
Intervention
Pimavanserin
Why stopped
The study was terminated for business reasons and not due to safety concerns.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-12-03